Polybia-MP1

CAS No. 872043-01-1

Polybia-MP1( ——— )

Catalog No. M40820 CAS No. 872043-01-1

Polybia-MP1 is an antimicrobial mastoparan peptide.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Polybia-MP1
  • Note
    Research use only, not for human use.
  • Brief Description
    Polybia-MP1 is an antimicrobial mastoparan peptide.
  • Description
    Polybia-MP1 is an antimicrobial mastoparan peptide.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    872043-01-1
  • Formula Weight
    1654.03
  • Molecular Formula
    C78H132N20O19
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Marcia Perez dos Santos Cabrera, et al. Selectivity in the mechanism of action of antimicrobial mastoparan peptide Polybia-MP1. Eur Biophys J. 2008 Jul;37(6):879-91.?
molnova catalog
related products
  • Secretin, porcine TF...

    Secretin, porcine TFA (Porcine secretin TFA) is a 27-amino acid peptide, acting on pancreatic acinar cells and ductal epithelial cells stimulating the production of bicarbonate rich fluid.Secretin porcine stimulates pancreatic and gastric secretions to aid in the diagnosis of pancreatic exocrine dysfunction and the diagnosis of gastrinoma.

  • Lys-(Hyp3)-Bradykini...

    Lys-[Hyp3]-Bradykinin a Bradykinin agonist. Lys-[Hyp3]-Bradykinin is a kinin, it can be isolated from human urine. Lys-[Hyp3]-Bradykinin can be used for the research of inflammation.

  • Icotinib Hydrochlori...

    Icotinib Hydrochloride is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity.